Literature DB >> 29397871

Outbreak of bacterial endocarditis associated with an oral surgery practice: New Jersey public health surveillance, 2013 to 2014.

Kathleen M Ross, Jason S Mehr, Rebecca D Greeley, Lindsay A Montoya, Prathit A Kulkarni, Sonya Frontin, Trevor J Weigle, Helen Giles, Barbara E Montana.   

Abstract

BACKGROUND: In October and November 2014, the New Jersey Department of Health received reports of 3 patients who developed Enterococcus faecalis endocarditis after undergoing surgical procedures at the same oral surgery practice in New Jersey. Bacterial endocarditis is an uncommon but life-threatening condition; 3 patients with enterococcal endocarditis associated with a single oral surgery practice is unusual. An investigation was initiated because of the potential ongoing public health risk.
METHODS: Public health officials conducted retrospective surveillance to identify additional patients with endocarditis associated with the practice. They interviewed patients using a standardized questionnaire. An investigative public health team inspected the office environment, interviewed staff, and reviewed medical records.
RESULTS: Public health officials identified 15 confirmed patients with enterococcal endocarditis of those patients who underwent procedures from December 2012 through August 2014. Among these patients, 12 (80%) underwent cardiac surgery. One (7%) patient died from complications of endocarditis and subsequent cardiac surgery. Breaches of recommended infection prevention practices were identified that might have resulted in transmission of enterococci during the administration of intravenous sedation, including failure to perform hand hygiene and failure to maintain aseptic technique when performing procedures and handling medications.
CONCLUSIONS: This investigation highlights the importance of adhering to infection prevention recommendations in dental care settings. No additional patients with endocarditis were identified after infection prevention and control recommendations were implemented. PRACTICAL IMPLICATIONS: Infection prevention training should be emphasized at all levels of professional dental training. All dental health care personnel establishing intravenous treatment and administering intravenous medications should be trained in safe injection practices.
Copyright © 2018 American Dental Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endocarditis; Enterococcus faecalis; health care–associated outbreak; infection control; injection safety

Mesh:

Year:  2018        PMID: 29397871      PMCID: PMC6951808          DOI: 10.1016/j.adaj.2017.10.002

Source DB:  PubMed          Journal:  J Am Dent Assoc        ISSN: 0002-8177            Impact factor:   3.634


  41 in total

1.  History forgotten is history relived: nosocomial infection control is also essential in the outpatient setting.

Authors:  Dennis G Maki; Christopher J Crnich
Journal:  Arch Intern Med       Date:  2005 Dec 12-26

2.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

3.  Relationships among and demographic predictors of dentists' self-reported adherence to national guidelines.

Authors:  M Dorsey; P Overman; W J Hayden; W Mayberry; B Requa-Clark; K Krust
Journal:  Soc Sci Med       Date:  1991       Impact factor: 4.634

4.  When your best friend turns on you; the impact of bad Propofol.

Authors:  Adam C Adler
Journal:  J Anesth       Date:  2015-02-17       Impact factor: 2.078

5.  Safe injection practices for administration of propofol.

Authors:  Cecil A King; Mary Ogg
Journal:  AORN J       Date:  2012-03       Impact factor: 0.676

6.  A comparison of infection control practices of different groups of oral specialists and general dental practitioners.

Authors:  G M McCarthy; J K MacDonald
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1998-01

Review 7.  Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group.

Authors:  Walter Wilson; Kathryn A Taubert; Michael Gewitz; Peter B Lockhart; Larry M Baddour; Matthew Levison; Ann Bolger; Christopher H Cabell; Masato Takahashi; Robert S Baltimore; Jane W Newburger; Brian L Strom; Lloyd Y Tani; Michael Gerber; Robert O Bonow; Thomas Pallasch; Stanford T Shulman; Anne H Rowley; Jane C Burns; Patricia Ferrieri; Timothy Gardner; David Goff; David T Durack
Journal:  J Am Dent Assoc       Date:  2008-01       Impact factor: 3.634

Review 8.  Virulence factors of Enterococcus faecalis: relationship to endodontic disease.

Authors:  Güven Kayaoglu; Dag Ørstavik
Journal:  Crit Rev Oral Biol Med       Date:  2004-09-01

Review 9.  Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998-2008.

Authors:  Nicola D Thompson; Joseph F Perz; Anne C Moorman; Scott D Holmberg
Journal:  Ann Intern Med       Date:  2009-01-06       Impact factor: 25.391

10.  Advancing infection control in dental care settings: factors associated with dentists' implementation of guidelines from the Centers for Disease Control and Prevention.

Authors:  Jennifer L Cleveland; Arthur J Bonito; Tammy J Corley; Misty Foster; Laurie Barker; G Gordon Brown; Nancy Lenfestey; Linda Lux
Journal:  J Am Dent Assoc       Date:  2012-10       Impact factor: 3.634

View more
  1 in total

Review 1.  Pros and Cons of CAD/CAM Technology for Infection Prevention in Dental Settings during COVID-19 Outbreak.

Authors:  Livia Barenghi; Alberto Barenghi; Umberto Garagiola; Alberto Di Blasio; Aldo Bruno Giannì; Francesco Spadari
Journal:  Sensors (Basel)       Date:  2021-12-22       Impact factor: 3.576

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.